Global Alzheimer's Platform Foundation Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Global Alzheimer's Platform Foundation's estimated annual revenue is currently $18.2M per year.(i)
  • Global Alzheimer's Platform Foundation's estimated revenue per employee is $243,000

Employee Data

  • Global Alzheimer's Platform Foundation has 75 Employees.(i)
  • Global Alzheimer's Platform Foundation grew their employee count by 42% last year.

Global Alzheimer's Platform Foundation's People

NameTitleEmail/Phone
1
Associate Director, GPS OperationsReveal Email/Phone
2
Senior Director, Programs, Marketing & CommunicationsReveal Email/Phone
3
Senior Director Operations, GPS ProgramReveal Email/Phone
4
Associate Director, Study EngagementReveal Email/Phone
5
Project Manager - Innovative Alzheimer's Diversity Prescreening StudyReveal Email/Phone
6
Manager External Communications and Public RelationsReveal Email/Phone
7
Senior Manager, Business Development OperationsReveal Email/Phone
8
Digital Marketing ManagerReveal Email/Phone
9
Senior Manager Recruitment and Clinical Trial OptimizationReveal Email/Phone
10
Marketing ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M360%N/AN/A
#2
$178.5M5291%N/AN/A
#3
$918.2M24299%N/AN/A
#4
$4.7M2514%N/AN/A
#5
$719.7M19046%N/AN/A
#6
$49.3M1664%N/AN/A
#7
$24.8M9215%N/AN/A
#8
$18M7425%N/AN/A
#9
$4M2111%N/AN/A
#10
$5.1M270%N/AN/A
Add Company

What Is Global Alzheimer's Platform Foundation?

The GAP Foundation is joining together leading academic researchers, pharmaceutical companies, nonprofit organizations and foundations, and governments around the world to reduce the time, cost and risk of Alzheimer’s clinical trials in order to speed innovative medicines to those with or at risk of Alzheimer’s disease. The GAP Foundation is establishing a standing global trial-ready platform to drive quality, efficiency, and innovation in Alzheimer’s Clinical Trials, seeking to reduce clinical testing cycle times by two years or more and to achieve greater uniformity in trial populations. It is doing that by building large, well-characterized trial-ready cohorts, a network of certified high-performance clinical trial sites, and an adaptive proof-of-concept trial mechanism

keywords:N/A

N/A

Total Funding

75

Number of Employees

$18.2M

Revenue (est)

42%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.5M7515%$25.4M
#2
$9.5M759%$22.5M
#3
$15.8M751%N/A
#4
$13.7M750%$3M
#5
$9.8M750%N/A